Robert May
Corporate Officer/Principal bei Affinia Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Robert May
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
26
| Extinct | Biotechnology | 26 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA.
17
| Holding Company | Biotechnology | 17 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Robert May
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member President Founder Director of Finance/CFO | |
| INTERMUNE INC | Biotechnology | Corporate Officer/Principal Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Founder Director/Board Member Founder Corporate Officer/Principal | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a clinical stage biotechnology company based in Lake Forest, IL. Jaguar Gene Therapy LLC is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company has a proven team of experts who have experience in bringing novel gene therapy treatments to patients and their families. Jaguar is rapidly advancing an initial pipeline of three programs, including targeting severe neurodevelopmental disorders, type 1 galactosemia, and type 1 diabetes. The company partner with Advanced Medicine Partners for manufacturing their therapeutics. Key investors include Deerfield Management Company, Arch Venture Partners, and Eli Lilly and Company. The company was founded by Daniel Gallo, and Joseph Nolan has been the CEO since 2020. | Medical/Nursing Services | Director of Finance/CFO Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AKOUOS | Biotechnology | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| University of Illinois | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Biotechnology | Chairman Director/Board Member Corporate Officer/Principal | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| University of Notre Dame | College/University | Masters Business Admin Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| PROTHENA CORPORATION PLC | Biotechnology | Chairman Director/Board Member | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Graduate Degree | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Undergraduate Degree | |
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Chairman | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Private Equity Investor Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Graduate Degree | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| 4D MOLECULAR THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal President | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree | |
| QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Raptor Pharmaceuticals Europe BV
 Raptor Pharmaceuticals Europe BV Miscellaneous Commercial ServicesCommercial Services Part of Amgen, Inc., Raptor Pharmaceuticals Europe BV is a Dutch company that engages in research and experimental development in other physical and natural sciences. The company is based in Louveciennes, the Netherlands. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| DAIICHI SANKYO CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Lung Therapeutics, Inc.
 Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Director/Board Member | |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
| Texas A&M University | College/University | Graduate Degree | |
| RAPTOR PHARMACEUTICAL CORP | Pharmaceuticals: Major | Corporate Officer/Principal | |
Medocity, Inc.
 Medocity, Inc. Medical/Nursing ServicesHealth Services Medocity, Inc. develops a care platform that bridges the gap between the clinic and the patient?s home. It offers a patient-centric mobile solution that combines key aspects of disease-specific care into a platform that can be used on application and Web-based devices. The firm platform also tracks key symptoms and side effects in real time; displays reports and graphic summaries to understand the patient?s health status on a daily basis. The company is headquartered in Parsippany, NJ. | Medical/Nursing Services | Director/Board Member | |
Society of Kauffman Fellows
 Society of Kauffman Fellows Miscellaneous Commercial ServicesCommercial Services The Society of Kauffman Fellows is a venture capital fellowship program that aims to foster innovative leaders. The non-profit company is based in Palo Alto, CA. The program lasts for two years and includes industry events, summits, and a venture capital fund. The CEOs of the company are Jeff Harbach, Costello Trish. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Rutgers Robert Wood Johnson Medical School | College/University | Doctorate Degree | |
| Sandhill Therapeutics, Inc. | Director/Board Member | ||
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 45 |
| Frankreich | 2 |
| Irland | 2 |
| Schweiz | 2 |
| Belgien | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Health Services | 4 |
| Finance | 3 |
Operativ
| Director/Board Member | 168 |
| Corporate Officer/Principal | 81 |
| Independent Dir/Board Member | 78 |
| Undergraduate Degree | 31 |
| Chairman | 28 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ed Mathers Mathers | 47 |
| Paul Manning | 26 |
| Daniel Welch | 24 |
| Dave Grayzel | 23 |
| Charles Sigal | 20 |
| Sean Nolan | 18 |
| Philip Donenberg | 16 |
| Frank Verwiel | 16 |
| Sukumar Nagendran | 15 |
| Joao Siffert | 14 |
| Bong Koh | 14 |
| R. Session | 13 |
| Thomas Leggett | 10 |
| Luk Vandenberghe | 9 |
| Rick Modi | 9 |
- Börse
- Insiders
- Robert May
- Unternehmensverbindungen
